Yes , the delay cost 3 months , however .....
"The antibodies have now been successfully tested for performance, allowing the reagents to be configured into the immunoassay test kit, also known as an ELISA (enzyme linked immunosorbent assay), that can be used in clinical laboratories around the world."
Most interestingly is the updated timetable for PIQ ..... there are two licensing deals still
scheduled in December and another in Febuary....
View attachment 850781
PIQ is progressing..... and the hiring of two new Board members who have commercialisation
experience at a time when activity is increasing would seem to be justified...
All IMO.........GLTA
(20min delay)